These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3902323)

  • 41. Clinical usefulness of MR imaging of the breast in the evaluation of the problematic mammogram.
    Lee CH; Smith RC; Levine JA; Troiano RN; Tocino I
    AJR Am J Roentgenol; 1999 Nov; 173(5):1323-9. PubMed ID: 10541112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast MR imaging. An analysis of its role with respect to other imaging and interventional modalities.
    Brenner RJ
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):705-23. PubMed ID: 7489318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Magnetic resonance imaging: the evolution of breast imaging.
    Heywang-Köbrunner SH; Hacker A; Sedlacek S
    Breast; 2013 Aug; 22 Suppl 2():S77-82. PubMed ID: 24074797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feature extraction and classification of dynamic contrast-enhanced T2*-weighted breast image data.
    Torheim G; Godtliebsen F; Axelson D; Kvistad KA; Haraldseth O; Rinck PA
    IEEE Trans Med Imaging; 2001 Dec; 20(12):1293-301. PubMed ID: 11811829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MR imaging of the breast.
    Weinreb JC; Newstead G
    Radiology; 1995 Sep; 196(3):593-610. PubMed ID: 7644617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gadopentetate dimeglumine-enhanced chemical-shift MR imaging of the breast.
    Rubens D; Totterman S; Chacko AK; Kothari K; Logan-Young W; Szumowski J; Simon JH; Zachariah E
    AJR Am J Roentgenol; 1991 Aug; 157(2):267-70. PubMed ID: 1853803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffusion weighted imaging with background body signal suppression / T2 image fusion in magnetic resonance mammography for breast cancer diagnosis.
    Nechifor-Boilă IA; Bancu S; Buruian M; Charlot M; Decaussin-Petrucci M; Krauth JS; Nechifor-Boilă AC; Borda A
    Chirurgia (Bucur); 2013; 108(2):199-205. PubMed ID: 23618570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G; Topal U
    Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "Early" breast cancer detection using techniques other than mammography.
    Kopans DB
    AJR Am J Roentgenol; 1984 Sep; 143(3):465-8. PubMed ID: 6331722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast imaging: a view from the present to the future.
    Sickles EA
    Diagn Imaging Clin Med; 1985; 54(3-4):118-25. PubMed ID: 3896613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation.
    Mossa-Basha M; Fundaro GM; Shah BA; Ali S; Pantelic MV
    Radiographics; 2010 Oct; 30(6):1673-87. PubMed ID: 21071382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
    Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV
    Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
    Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
    Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening, imaging, and image-guided biopsy techniques for breast cancer.
    Smetherman DH
    Surg Clin North Am; 2013 Apr; 93(2):309-27. PubMed ID: 23464688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
    Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
    Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effectiveness of MR imaging in the assessment of invasive lobular carcinoma of the breast.
    Mann RM
    Magn Reson Imaging Clin N Am; 2010 May; 18(2):259-76, ix. PubMed ID: 20494311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MR imaging of the breast. Imaging and tissue characterization without intravenous contrast.
    Santyr GE
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):673-90. PubMed ID: 7489316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Magnetic resonance imaging characteristics of paraffinomas and siliconomas after mammoplasty.
    Wang J; Shih TT; Li YW; Chang KJ; Huang HY
    J Formos Med Assoc; 2002 Feb; 101(2):117-23. PubMed ID: 12099202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Magnetic resonance tomography. A new method in the diagnosis of breast cancer].
    Boné B; Isberg B; Perbeck L; Aspelin P
    Lakartidningen; 1993 Jul; 90(30-31):2590-2. PubMed ID: 8345763
    [No Abstract]   [Full Text] [Related]  

  • 60. New methods for the early detection and diagnosis of breast cancer.
    Henson DE
    J Natl Cancer Inst; 1984 Aug; 73(2):549-52. PubMed ID: 6589444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.